https://doi.org/10.1016/s0140-6736(16)31322-8
P
Parameswaran Nair
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
414
Papers
18.5K
Citations
62
h-index
188
i10-index
Parameswaran Nair is an academic researcher from University of British Columbia. The author has contributed to research in topics: Asthma and respiratory diseases & Respiratory and Cough-Related Research & Eosinophilic Esophagitis. The author has an h-index of 62, co-authored 352 publications.
ORCID: 0000-0002-1041-9492Papers by this author
worksBenralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial
2016 · The Lancet · 1,338 citations
Revisiting <scp>T</scp>ype 2‐high and <scp>T</scp>ype 2‐low airway inflammation in asthma: current knowledge and therapeutic implications
2016 · Clinical & Experimental Allergy · 365 citations
https://doi.org/10.1111/cea.12880
Revised ISHAM-ABPA working group clinical practice guidelines for diagnosing, classifying and treating allergic bronchopulmonary aspergillosis/mycoses
2024 · European Respiratory Journal · 170 citations
https://doi.org/10.1183/13993003.00061-2024
Regulation of human airway smooth muscle cell migration and relevance to asthma
2017 · Respiratory Research · 114 citations
https://doi.org/10.1186/s12931-017-0640-8
Therapeutic potential of anti-IL-6 therapies for granulocytic airway inflammation in asthma
2015 · Allergy Asthma and Clinical Immunology · 83 citations
https://doi.org/10.1186/s13223-015-0081-1
Persistence of pulmonary tertiary lymphoid tissues and anti-nuclear antibodies following cessation of cigarette smoke exposure
2014 · Respiratory Research · 51 citations
https://doi.org/10.1186/1465-9921-15-49
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat